Try it
Biochemistry · Molecular biology and genetics: UGT1A1 and irinotecan
Sample itemA man with colon cancer develops severe neutropenia and diarrhoea after irinotecan. He is homozygous for the UGT1A1*28 variant. What is the mechanism?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Impaired glucuronidation of the active metabolite SN-38
Irinotecan is converted to the active metabolite SN-38, which is inactivated by UGT1A1-mediated glucuronidation. Reduced UGT1A1 expression allows SN-38 to accumulate and causes neutropenia and diarrhoea. The same enzyme is involved in Gilbert syndrome.
Option by option
A. Impaired methylation by thiopurine methyltransferase
Thiopurine methyltransferase handles thiopurines, not irinotecan.
B. Impaired glucuronidation of the active metabolite SN-38 (correct)
Correct. SN-38 is cleared by UGT1A1 and builds up when the enzyme is reduced.
C. Impaired activation of the prodrug by carboxylesterase
Reduced activation would lower toxicity, not raise it.
D. Impaired breakdown of the drug by dihydropyrimidine dehydrogenase
Dihydropyrimidine dehydrogenase handles fluorouracil, not irinotecan.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…